Empowering Early Cancer
Detection
A key to managing cancer is early detection. ClearNote Health makes this possible by finding signals of cancer in the blood early, when treatment may be the most effective.
Our Portfolio
Measuring Active Disease Biology
Avantect® Early Cancer Detection Tests
Our goal is to detect cancer in its earliest stages. Our simple DNA-based blood tests are designed to make earlier diagnosis possible for patients at elevated risk for cancers with limited detection options.
Virtuoso™ Epigenomics Platform
Virtuoso measures active disease biology from drug discovery through development, including dynamic insights into therapy response and resistance, all from a blood draw. Discover what you might be missing in your liquid biopsy data.
ClearNote Health focuses on cancers with high mortality rates for which there are no or very limited detection options.
We have adopted a novel strategy toward developing single-disease and targeted multi-cancer panels to provide high-impact clinical value.
